GlassScriptPhysician profile
Karen G Kohut
NPI 1720116502
$1,076.05
in general payments reported to CMS, 2019-2025
9 companies · $310 in 2025
The $310 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.00 · 2020: $70.99 · 2021: $70.50 · 2022: $13.96 · 2023: $364 · 2024: $221 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $389.36 | 2023-2025 | |
| Minerva Surgical, INC | $203.05 | 2023 | |
| Merck Sharp & Dohme LLC | $180.01 | 2020-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Insightec,INC | $143.24 | 2025 | Exablate |
| Glaxosmithkline, LLC. | $80.23 | 2019-2024 | Bexsero, Shingrix, Arexvy |
| Organon LLC | $23.43 | 2021-2022 | |
| Hologic Sales and Service, LLC | $19.59 | 2024 | Aptima |
| Dexcom, INC. | $18.64 | 2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $18.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Kohut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.